Description
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Purity | ≥98% |
|---|---|
| Formula | C25H39H7O8 |
| Formula Wt. | 565.63 |
| Synonym | EHIPA. |
| Solubility | Soluble in water (2 mg/mL). |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Gartner TK, Loudon R, Taylor DB. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1446-52. PMID: 1953789.
Arginine source used to increase NO production....
Benzimidazole; microtubule polymerization inhib...
Natriuretic, vasodilatory peptide; B1/2 agonist...
CDK9 inhibitor.
PP2A activator, Sphk1 and PKC inhibitor.
AurK, FLT3, Abl inhibitor.
Endogenous neuropeptide hormone; somatostatin a...
Histone H2-derived antimicrobial peptide found ...
Recombinant HIV-1 glycoprotein antigen fragment...
5-Lipoxygenase inhibitor.
Atazanavir metabolite; HIV protease inhibitor.<...
Peptide toxin found in Conus snails; nAChR inhi...
Anionic lipopeptide, alters cell membrane organ...
DAT inhibitor.
Prostacyclin analog
AMPK activator, D1-4, 5-HT1A/2/3/6/7, M1-5 mACh...
MurA and isopentenyl mevalonate kinase inhibito...
Laminin-derived peptapeptide.
Antioxidant; Nrf2 activator.